Roche's third-quarter sales rose 6 percent to 13.1 billion Swiss francs ($13.37 billion). » Read More
By: Elizabeth Gurdus
Jim Cramer explains why the bulls are right and the stock of Johnson & Johnson is worth owning. » Read More
Collaborative relationships with hospitals across the globe are improving patient outcomes and operational efficiencies.
President Donald Trump last week cut off cost-sharing reduction reimbursements worth billions of dollars to Obamacare insurers.
How Trump's plan to declare the opioid crisis a national emergency could put a huge dent in drug industry profits, says Jake Novak.
The Trump administration last week stopped paying insurers cost-sharing reduction reimbursements.
The proposal would fund billions of dollars worth of Obamacare reimbursements to insurers, which Trump cut off last week.
The tribe is a co-plaintiff with SRC Labs, which claims its data processing technology patents have been infringed for years.
The makers of cancer drugs also make vials with too much medication for many patients, ProPublica reports.
Trump is the wildcard for 2018 insurance rates, Vox reports.
The lead singer of rock band The Tragically Hip was diagnosed with brain cancer in 2015.
With different plan types, you should carefully weigh which one is right for you.
Health insurer Anthem says it will start managing its billions of dollars of patient prescriptions itself in 2020.
With Obamacare premiums set to see a big spike for 2018, online health insurance broker eHealth is out with a new insurance offering.
Regulators have granted a priority review to AstraZeneca's ovarian cancer drug Lynparza as a treatment for breast cancer.
Now, it's about whether an all-GOP government can accept political limits, allow bipartisan compromise and protect citizens from harm.
President Trump's open vendetta against Obamacare is problematic, says Abbe Gluck in Vox.
President Trump last week killed bllions of dollars of payments to insurers.
Insurers in Florida alone will lose about $200 million, and California insurers will lose about $107 million because of Trump's decision.
Get the best of CNBC in your inbox